Visit JCR Japan
Visit JCR Japan
Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us
JCR Pharmaceuticals
Revision of consolidated financial forecasts for fiscal year ended March 31, 2025
by JCR Pharmaceuticals
Financial summary consolidated financial results for the nine months ended December 31, 2024 (FY2024) (Japanese standard)
by JCR Pharmaceuticals
1
…
8
9
10
Privacy Preference Center
Privacy Preferences